NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

GE HealthCare Technologies Inc. (GEHC) Stock Analysis

GE HealthCare Technologies Inc. (GEHC) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

GEHC

$68.86

−$0.86 (−1.23%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare GEHC with… →

GEHC Key Statistics

As of Sep 4, 2026
Trading
Open
$68.99
Previous Close
$69.72
Day's Range
68.49–69.26
52-Week Range
58.75–89.77
Volume
2.81M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.82
Valuation
Market Cap
$31.10B
P/E Ratio
15.87
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
12.73
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.74
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.46
EPS (ttm)Profit attributable to each share over the last twelve months.
4.34
Financials (FY)
Revenue (FY)
$20.63B+4.84%
Net Income (FY)
$2.08B+4.57%
Profit marginThe share of revenue left as profit after all costs and taxes.
9.33%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
451.69M
1-Year Return
−6.92%
Dividend and dates
Dividend
$0.14+0.20%
Ex-Dividend Date
July 24, 2026
Earnings Date
October 28, 2026estimated
Avg Volume
4.46M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

GEHC Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−15.92%
2025+5.11%
2024+1.26%
2023+32.60%
2022 (partial year)−2.70%

As of September 4, 2026.

GEHC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$20.63B$2.08B10.1%
2024$19.67B$1.99B10.1%
2023$19.55B$1.57B8.0%
2022$18.34B$1.92B10.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$20.63B$8.25B$2.76B$2.08B10.1%
2024$19.67B$8.21B$2.63B$1.99B10.1%
2023$19.55B$7.92B$2.44B$1.57B8.0%
2022$18.34B$7.18B$2.52B$1.92B10.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

GEHC Dividend History

$0.14+16.7% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.113—
2025$0.144+16.7%
2024$0.124+33.3%
2023$0.093—

Most recent payment: $0.03 per share, ex-dividend July 24, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

GEHC Valuation vs Medical Devices Median

Median of 151 stocks
MetricGEHCMedical Devices medianvs median
P/E15.8726.8041% below
P/S ratio1.462.9851% below
Profit margin9.33%−1.69%11.0 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values GE HealthCare Technologies Inc. (GEHC) at $31.10B. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 54,000 employees.

The most recent close on file for GEHC is $68.86, dated September 4, 2026. That is −$0.86 (−1.23%) against the previous close. The 52-week range on file runs from $58.75 to $89.77. The latest close sits 17.21% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $20.63B. That is +4.84% against the prior fiscal year, when revenue was $19.67B. Net income for the same year was $2.08B. That is +4.57% against the prior fiscal year. Profit margin runs at 9.33%. That is 11 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to 4.34.

Across the 4 fiscal years on file, revenue moves from $18.34B in 2022 to $20.63B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

GEHC trades at a trailing price-to-earnings ratio of 15.87. That is 40.78% below the Medical Devices median of 26.8. On forward earnings the ratio is 12.73. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.74. Measured against sales, the shares trade at 1.46 times revenue. On price-to-sales that is 50.86% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Beta against the wider market is reported at 0.82. Annualized volatility over the trailing 3 years is 33.38%. The trailing one-year price return is −6.92%. Measured over 3 years, that is −0.02% a year compounded.

Growth & Income

GEHC pays a dividend yielding 0.2%. That is 1.2 percentage points below the Medical Devices median yield of 1.38%. At the indicated rate that is $0.14 a share a year. The ex-dividend date on file is July 24, 2026. Dividends are recorded for 4 calendar years; 2026 shows 3 payments totalling $0.11 a share. The year before, 2025, totalled $0.14 a share.

Across the complete calendar years on file, 2023 returned +32.60% and 2024 returned +1.26%. Of the 3 complete calendar years on file, 3 finished higher. 2026 is still running; the price is −15.92% year to date.

Peer Comparison

GE HealthCare Technologies Inc. (GEHC) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
GE HealthCare Technologies Inc. GEHC $31.10B 15.9
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. GE HealthCare Technologies Inc. trades at a P/E of 15.9.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Visit website →